hERG potassium channel inhibition by ivabradine may...

  • Main
  • 2015 / 07
  • hERG potassium channel inhibition by ivabradine may...
Therapeutic Advances in Drug Safety 2015 / 07

hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes

Hancox, J. C., Melgari, D., Dempsey, C. E., Brack, K. E., Mitcheson, J., Ng, G. A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Therapeutic Advances in Drug Safety
DOI:
10.1177/2042098615595546
Date:
July, 2015
File:
PDF, 371 KB
english, 2015
Conversion to is in progress
Conversion to is failed